Timothy j Schroeder insider trades: Inmune Bio (INMB) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Timothy reports to the SEC
Open-market buys and sales
6 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jul 12, 2023 | INMB | ↓ Sell | 10,000 | $11.01 | $110K | Indirect | Jul 14, 2023 (2d) |
| Jul 13, 2021 | INMB | ↓ Sell | 14,480 | $27.63 | $400K | Indirect | Jul 14, 2021 (1d) |
| Jul 9, 2021 | INMB | ↓ Sell | 30,000 | $23.20 | $696K | Indirect | Jul 12, 2021 (3d) |
| Jun 14, 2021 | INMB | ↓ Sell | 10,000 | $19.02 | $190K | Indirect | Jun 15, 2021 (1d) |
| Jun 10, 2021 | INMB | ↓ Sell | 10,000 | $17.01 | $170K | Indirect | Jun 14, 2021 (4d) |
| Mar 31, 2021 | INMB | ↓ Sell | 10,000 | $11.95 | $119K | Indirect | Apr 1, 2021 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Timothy j Schroeder's insider trades
Timothy j Schroeder is a director at Inmune Bio (INMB). Since Mar 31, 2021, Timothy has reported no open-market purchases and 6 sales worth $1.7M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (9 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every INMB insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.